Patents by Inventor Mary Ellen Ryback

Mary Ellen Ryback has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Renal cell carcinoma treatment
    Patent number: 6605273
    Abstract: Methods for treating treatment-naive as well as treatment-experienced patients having RCC to achieve at least a partial tumor response involving administering a therapeutically effective amount of pegylated interferon-alpha, e.g., pegylated interferon alpha-2b as monotherapy or in association with a therapeutically effective amount of IL-2 are disclosed.
    Type: Grant
    Filed: July 9, 2001
    Date of Patent: August 12, 2003
    Assignee: Schering Corporation
    Inventors: Mary Ellen Ryback, Esther Helen Rose